AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
Key PointsAbbVie demonstrates resilient revenue growth fueled by its next-generation immunology and aesthetics portfolio...
Nasdaq News: Markets
U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse
Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved ZENBEXUS (iberdomide) in combination with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd) for the treatment of adult patients with multiple myeloma who have received at least...
Business Wire
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration PR Newswire SAN DIEGO, Aug. 13, 2026 SAN DIEGO...
PR Newswire
Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas
Bristol Myers Squibb (NYSE:BMY) today announced the selection of Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus, representing an approximately $2.3 billion investment designed to accelerate the delivery of next-generation medicines to patients. The campus...
Business Wire
Bristol Myers Squibb Reports Second Quarter Financial Results for 2026
Bristol Myers Squibb (NYSE: BMY) today reported second quarter 2026 financial results. Visit the companys Investor Relations website at http://investor.bms.com to view the detailed second quarter 2026 earnings press release and investor presentation. The company will host a conference call and live...
Business Wire
Apple, Microsoft And 3 Stocks To Watch Heading Into Thursday
U.S. stock futures trading higher, focus on Apple, Microsoft, Amazon earnings. Meta posts mixed results, Bristol-Myers Squibb to release earnings.read more...
Benzinga
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
In times of market turbulence, dividend-yielding stocks are popular for investors. Check out analyst ratings for high-yielding stocks and recent news on Bristol-Myers Squibb, GSK, and Medtronic PLC on Benzinga's Analyst Stock Ratings page.Investors turn to dividend-yielding stocks in turbulent...
Benzinga
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
Bristol Myers Squibb (NYSE: BMY, BMS), a global biopharmaceutical leader, today announced it will expand its compute infrastructure to deploy an NVIDIA DGX SuperPOD with DGX Vera Rubin NVL72 systems, giving BMS the most powerful and energy-efficient single-owned NVIDIA infrastructure in life...
Business Wire
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for mezigdomide in combination with carfilzomib and dexamethasone (MeziKd) in patients with relapsed or refractory multiple myeloma (RRMM). Mezigdomide is an...
Business Wire
Is Bristol-Myers Squibb Company (BMY) Stock at Risk From Proposed Medicare Drug Price Negotiation Updates?
Is Bristol-Myers Squibb Company (BMY) Stock at Risk From Proposed Medicare Drug Price Negotiation Updates...
Yahoo! Finance: News